RHD in India: Are we ready to shift from secondary prophylaxis to vaccinating high-risk children?

Current Science

Volumn 97, Issue 3, 2009, Pages 397-404

  Krishna Kumar, R ^a   Paul, Mary ^a   Francis, Paul T ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Epidemiology; Prevention; Rheumatic fever; Rheumatic heart disease; Secondary prophylaxis; Vaccines

Indexed keywords

STREPTOCOCCUS GROUP A; STREPTOCOCCUS SP. 'GROUP A';

EID: 71849095379     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Gordis, L., The virtual disappearance of rheumatic fever in the United States: Lessons in the rise and fall of disease. Circulation, 1985, 72, 1155-1162.
2. Mas Lago, P., Eradication of poliomyelitis in Cuba: a historical perspective. Bull. WHO, 1999, 77, 681-687.
3. Rheumatic fever and rheumatic heart disease. World Health Organisation Technical Report Series No. 923, 2004, pp. 1-122.
4. Kumar, R. K., Rammohan, R., Kaplan, E. L. and Narula, J. S., Epidemiology of streptococcal pharyngitis, rheumatic fever and rheumatic heart disease. In Rheumatic Fever (eds Narula, J. et al.), American Registry of Pathology, Washington, DC, 1999, pp. 41-78.
5. Veasy, L. G. et al., Persistence of acute rheumatic fever in the intermountain area of the United States. J. Pediatr., 1994, 124, 9-16.
6. Padmavati, S., Epidemiology of cardiovascular disease in India: I. Rheumatic heart disease. Circulation, 1962, 25, 703-710.
7. Padmavati, S., Rheumatic fever and rheumatic heart disease in developing countries. Bull. WHO, 1978, 56, 543-550.
8. Koshi, G., Benjamin, V. and Cherian, G., Rheumatic fever and rheumatic heart disease in rural South Indian children. Bull. WHO, 1981, 59, 599-603.
9. Community control of rheumatic fever and rheumatic heart disease. Report of ICMR Task Force study, ICMR, Delhi 1994.
10. Pilot study on the feasibility of utilizing the existing school health services in Delhi for the control of RF/RHD. ICMR final report, 1990.
11. Padmavati, S., Present status of rheumatic fever and rheumatic heart disease in India. Indian Heart J., 1995, 47, 395-398.
12. Patel, D. C., Patel, N. I., Patel, J. D. and Patel, S. D., Rheumatic fever and rheumatic heart disease in school children of Anand. J. Assoc. Physicians India, 1986, 34, 837-839.
13. Avasthi, G., Singh, D., Singh, C., Aggarwal, S. P., Bidwai, P. S. and Avasthi, R., Prevalence survey of rheumatic fever (RF) and rheumatic heart disease (RHD) in urban and rural school children in Ludhiana. Indian Heart J., 1987, 39, 26-28.
14. Grover, A., Dhawan, A., Iyengar, S. D., Anand, I. S., Wahi, P. L. and Ganguly, N. K., Epidemilogy of rheumatic fever and rheumatic heart disease in a rural community in northern India. Bull. WHO, 1993, 71, 59-66.
15. Thakur, J. S., Negi, P. C., Ahluwalia, S. K. and Vaidya, N. K., Epidemiological survey of rheumatic heart disease among school children in the Shimla Hills of northern India: prevalence and risk factors. J. Epidemiol. Commun. Health, 1996, 50, 62-67.
16. Kumar, P., Garhwal, S. and Chaudhary, V., Rheumatic heart disease: a school survey in a rural area of Rajasthan. Indian Heart J., 1992, 44, 245-246.
17. Gupta, I., Gupta, M. L., Parihar, A. and Gupta, C. D., Epidemiology of rheumatic and congenital heart diseases in school children. J. Indian Med. Assoc., 1992, 90, 57-59.
18. Vashistha, V. M., Kalra, A., Kalra, K. and Jain, V. K., Prevalence of rheumatic heart disease in school children. Indian Pediatr., 1993, 30, 53-56.
19. Agarwal, A. K., Yunus, M., Ahmad, J. and Khan, A., Rheumatic heart disease in India. J. R. Soc. Health, 1995, 115, 303-309.
20. Kaul, R. R., Masoodi, M. A., Wani, K. A., Hassan, G. and Qureshi, K. A., Prevalence of rheumatic heart disease in school children (5-15 years) in a rural block of Srinagar, JK Practitioner, 2005, 12, 160-162.
21. Lalchandani, A., Kumar, H. R. P. and Alam, S. M., Prevalence of rheumatic fever and rheumatic heart disease in rural and urban school children of district Kanpur. Indian Heart J., 2000, 52, 672.
22. Jose, V. J. and Gomathi, M., Declining prevalence of rheumatic heart disease in rural schoolchildren in India: 2001-2002. Indian Heart J., 2003, 55, 158-160.
23. Periwal, K. L., Gupta, B. K., Panwar, R. B., Khatri, P. C., Raja, S. and Gupta, R., Prevalence of rheumatic heart disease in school children in Bikaner: an echocardiographic study. J. Assoc. Physicians India, 2006, 54, 279-282.
24. Misra, M. et al., Prevalence of rheumatic heart disease in schoolgoing children of eastern Uttar Pradesh. Indian Heart J., 2007, 59, 42-43.
25. Routray, S. N., Has the prevalence of rheumatic fever/rheumatic heart disease really changed? A hospital-based study. Indian Heart J., 2003, 55, 152-157.
26. Tandon, R., Is it possible to prevent rheumatic fever. Indian Heart J., 2004, 56, 677-679.
27. Kumar, R., Thakur, J. S., Aggarwal, A. and Ganguly, N. K., Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India. Indian Heart J., 1997, 49, 282-288.
28. Saran, R. K., Sinha, N., Hasan, M., Bhatia, M. C. and Bhatia, K. B., Is monthly injection of benzathine penicillin adequate for rheumatic fever prophylaxis in our country? J. Assoc. Physicians India, 1985, 33, 641-643.
29. Ravisha, S., Tullu, M. S. and Kamat, J. R., Rheumatic fever and rheumatic heart disease: clinical profile of 550 cases in India. Arch. Med. Res., 2003, 34, 382-387.
30. Sainani, G. and Sainani, A. R., Rheumatic fever: How relevant in India today. J. Assoc. Physicians India (Suppl.), 2006, 54, 42-47.
31. World Health Organisation, Group A streptococcal vaccine development: current status and issues of relevance to less developed countries. Group A streptococcal disease. Discussion papers on child health. WHO, Geneva, 2005; www.who.int/child_adolescent_health/documents/research/en/index.html (accessed 9 May 2007).
32. McNeil, S. A. et al., Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis., 2005, 41, 1123-1124.
33. Brandt, E. R. et al., Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology, 1996, 89, 331-337.
34. Hruby, D. E., Hodges, W. M., Wilson, E. M., Franke, C. A. and Fischetti, V. A., Expression of streptococcal M protein in mammalian cells. Proc. Natl. Acad. Sci. USA, 1988, 85, 5714-5717.
35. Salvadori, L. G., Blake, M. S., McCarty, M., Tai, J. Y. and Zabriskie, J. B., Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. J. Infect. Dis., 1995, 171, 593-600.
36. Ji, Y., Carlson, B., Kondagunta, A. and Cleary, P. P., Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus. Infect. Immunol., 1997, 65, 2080-2087.
37. Valentin-Weigand, P., Talay, S. R., Kaufhold, A., Timmis, K. N. and Chhatwal, G. S., The fibronectin binding domain of the Sfb protein adhesin of streptococcus pyogenes occurs in many group A streptococci and does not cross-react with heart myosin. Microb. Pathog., 1994, 17, 111-120.
38. Kapur, V., Maffei, J. T., Greer, R. S., Li, L. L., Adams, G. J. and Musser, J. M., Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. Microb. Pathog., 1994, 16, 443-450.
39. Yokoyama, Y. and Harabuchi, Y., Intranasal immunization with lipoteichoic acid and cholera toxin evokes specific pharyngeal IgA and systemic IgG responses and inhibits streptococcal adherence to pharyngeal epithelial cells in mice. Int. J. Pediatr. Otorhinolaryngol., 2002, 63, 235.
40. Dey, N. et al., High diversity of group A streptococcal emm types in an Indian community: the need to tailor multivalent vaccines. Clin. Infect. Dis., 2005, 40, 46-51.